PARECOXIB SODIUM

China [CN]

Parecoxib sodium is a benchmark injectable analgesic for postoperative pain management. Its core competitive advantages include rapid onset of action, high gastrointestinal safety, no impact on platelets, and opioid-sparing effects. It is suitable for short-term postoperative analgesia in multiple departments. Quality control focuses on sterility, endotoxin levels, and post-reconstitution stability to ensure safe and effective clinical use.